Law & Regulation

DealWatch – a subdued first half for corporate lawyers

Victoria Young
Wed, 06 Jul 2022

DealWatch – a subdued first half for corporate lawyers

Simpson Grierson's Andrew Matthews said foreign investment remained strong. (Image: Supplied)

Victoria Young
Wed, 06 Jul 2022

The past two months have been quieter for the country’s mergers and acquisitions (M&A) lawyers, who are still optimistic about deal flow through to the end of the year.Simpson Grierson’s M&A deal analysis used Mergermarket data for the first half of 2022 and found record highs have calmed down closer to pre-pandemic levels.There were 51 deals in the first half of 2021, compared with 35 this half, a 35% decline, the data showed. By value, this equated to US$6.1 billion in the first half of 2021 compared with US$5.5b in the fi...

Unlock all stories
free for 10 days

Trustworthy, balanced journalism every day from our growing team of New Zealand business reporters and commentators, plus more in our weekend magazine section, The Life.

Instant News Alerts based on keywords you choose or journalists you follow
Our Daily Digest of all stories at 6am, midday or 6pm
Comprehensive business and markets coverage
News via email, web and Apple/Android apps

Try for 10 days without paying and if you’re not convinced cancel with just two clicks.

Find out more

Subscribe now

Name

E-Mail Address

Password

Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Confirm Password

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Cardholder's Name

Card

You will be charged in 10 days unless you cancel beforehand. We will remind you three times before charging you.
All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service {{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Or Subscribe with Google

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets FREE

A2 shares plunge over FDA formula deferral

Staff reporters | Wed, 10 Aug 2022

A2 shares dropped 11% to $5.01 in early morning trading opened but made up a bit of lost ground by the end of the day.

Tourism

Tourism needs to 'embrace' job-sharing to spur recovery – report

Brent Melville | Wed, 10 Aug 2022

An industry that lost more than a third of its workforce during the pandemic needs to start thinking differently about work sharing.

Primary Sector

A2 Milk gets shot down because of issues in application

Rebecca Howard | Wed, 10 Aug 2022

The FDA continues to work around the clock to address current supply challenges, including reviewing a number of requests from manufacturers for enforcement discretion, as quickly as possible, a spokesperson said.

DealWatch – a subdued first half for corporate lawyers

Subscribe now

Or Subscribe with Google

Not convinced yet?

Your company has a subscription

Team